Anderson CD, Pinson CW, Berlin J, Chari RS: Diagnosis and treatment of cholangiocarcinoma. Oncologist. 2004, 9: 43-57.
Article
PubMed
Google Scholar
El-Serag HB, Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007, 132: 2557-2576. 10.1053/j.gastro.2007.04.061.
Article
CAS
PubMed
Google Scholar
Tyson GL, El-Serag HB: Risk factors for cholangiocarcinoma. Hepatology. 2011, 54: 173-184.
Article
CAS
PubMed
PubMed Central
Google Scholar
Eckel F, Brunner T, Jelic S: On behalf of the ESMO Guidelines Working Group: Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010, 21: v65-v69. 10.1093/annonc/mdq167.
Article
PubMed
Google Scholar
Jelic S, Sotiropoulos GC: Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010, 21 (5): 59-64.
Article
Google Scholar
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J-F, De Oliveira AC, Santoro A, Raoul J-L, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz J-F, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008, 359: 378-390. 10.1056/NEJMoa0708857.
Article
CAS
PubMed
Google Scholar
Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J: Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010, 362: 1273-1281. 10.1056/NEJMoa0908721.
Article
CAS
PubMed
Google Scholar
Lencioni R: Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy. Crit Rev Oncol Hematol. 2012, 83: 216-224. 10.1016/j.critrevonc.2011.10.008.
Article
PubMed
Google Scholar
Cantore M, Mambrini A, Fiorentini G, Rabbi C, Zamagni D, Caudana R, Pennucci C, Sanguinetti F, Lombardi M, Nicoli N: Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors. Cancer. 2005, 103: 1402-1407. 10.1002/cncr.20964.
Article
CAS
PubMed
Google Scholar
Lencioni R, Crocetti L: Local-regional treatment of hepatocellular carcinoma. Radiology. 2012, 262: 43-58. 10.1148/radiol.11110144.
Article
PubMed
Google Scholar
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer. 2012, 48: 599-641.
Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology. 2003, 37: 429-442. 10.1053/jhep.2003.50047.
Article
CAS
PubMed
Google Scholar
Fiorentini G, Aliberti C, Tilli M, Mulazzani L, Graziano F, Giordani P, Mambrini A, Montagnani F, Alessandroni P, Catalano V, Coschiera P: Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. Anticancer Res. 2012, 32: 1387-1395.
CAS
PubMed
Google Scholar
Martin R, Geller D, Espat J, Kooby D, Sellars M, Goldstein R, Imagawa D, Scoggins C: Safety and efficacy of trans arterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic review. Hepatogastroenterology. 2012, 59: 255-260.
PubMed
Google Scholar
Kemeny NE, Schwartz L, Gönen M, Yopp A, Gultekin D, D’Angelica MI, Fong Y, Haviland D, Gewirtz AN, Allen P, Jarnagin WR: Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results?. Oncol. 2011, 80: 153-159. 10.1159/000324704.
Article
CAS
Google Scholar
Nagano H: Treatment of advanced hepatocellular carcinoma: intraarterial infusion chemotherapy combined with interferon. Oncol. 2010, 78 (Suppl 1): 142-147.
Article
CAS
Google Scholar
Mocellin S, Pilati P, Lise M, Nitti D: Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?. J Clin Oncol. 2007, 25: 5649-5654. 10.1200/JCO.2007.12.1764.
Article
PubMed
Google Scholar
Bouchahda M, Lévi F, Adam R, Rougier P: Modern insights into hepatic arterial infusion for liver metastases from colorectal cancer. Eur J Cancer. 2011, 47: 2681-2690. 10.1016/j.ejca.2011.06.037.
Article
CAS
PubMed
Google Scholar
Kingham TP, D’Angelica M, Kemeny NE: Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases. J Surg Oncol. 2010, 102: 988-995. 10.1002/jso.21753.
Article
PubMed
Google Scholar
Heinrich S, Petrowsky H, Schwinnen I, Staib-Sebler E, Gog C, El-Ganainy A, Gutt C, Müller H-H, Lorenz M: Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases. Surgery. 2003, 133: 40-48. 10.1067/msy.2003.37.
Article
PubMed
Google Scholar
Ricke J, Hildebrandt B, Miersch A, Nicolaou A, Warschewske G, Teichgräber U, Lopez Hänninen E, Riess H, Felix R: Hepatic arterial port systems for treatment of liver metastases: factors affecting patency and adverse events. J Vasc Interv Radiol. 2004, 15: 825-833. 10.1097/01.RVI.0000136992.96374.60.
Article
PubMed
Google Scholar
Hildebrandt B, Pech M, Nicolaou A, Langrehr JM, Kurcz J, Bartels B, Miersch A, Felix R, Neuhaus P, Riess H, Dörken B, Ricke J: Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: a Phase II-study and historical comparison with the surgical approach. BMC Cancer. 2007, 7: 69-10.1186/1471-2407-7-69.
Article
PubMed
PubMed Central
Google Scholar
Nehls O, Klump B, Arkenau HT, Hass HG, Greschniok A, Gregor M, Porschen R: Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial. Br J Cancer. 2002, 87: 702-704. 10.1038/sj.bjc.6600543.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lim JY, Jeung H-C, Mun HS, Lee DK, Paik YH, Lee SJ, Yoon DS, Cho JY: Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma. Anticancer Drugs. 2008, 19: 631-635. 10.1097/CAD.0b013e3283017f94.
Article
CAS
PubMed
Google Scholar
Yamashita T, Arai K, Sunagozaka H, Ueda T, Terashima T, Yamashita T, Mizukoshi E, Sakai A, Nakamoto Y, Honda M, Kaneko S: Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinoma. Oncol. 2011, 81: 281-290. 10.1159/000334439.
Article
CAS
Google Scholar
Wieners G, Pech M, Hildebrandt B, Peters N, Nicolaou A, Mohnike K, Seidensticker M, Sawicki M, Wust P, Ricke J: Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal “liver-only” metastases: hepatic interstitial brachytherapy plus regional chemotherapy. Cardiovasc Intervent Radiol. 2009, 32: 937-945. 10.1007/s00270-009-9597-4.
Article
PubMed
Google Scholar
Deschamps F, Elias D, Goere D, Malka D, Ducreux M, Boige V, Auperin A, De Baere T: Intra-arterial hepatic chemotherapy: a comparison of percutaneous versus surgical implantation of port-catheters. Cardiovasc Intervent Radiol. 2011, 34: 973-979. 10.1007/s00270-010-9996-6.
Article
CAS
PubMed
Google Scholar
Oberfield RA, Sampson E, Heatley GJ: Hepatic artery infusion chemotherapy for metastatic colorectal cancer to the liver at the lahey clinic: comparison between two methods of treatment, surgical versus percutaneous catheter placement. Am J Clin Oncol. 2004, 27: 376-383. 10.1097/01.COC.0000071465.29907.A5.
Article
PubMed
Google Scholar
Dudeck O, Ricke J: Advances in regional chemotherapy of the liver. Expert Opin Drug Deliv. 2011, 8: 1057-1069. 10.1517/17425247.2011.574125.
Article
CAS
PubMed
Google Scholar
Hong K, Geschwind J-FH: Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma. Semin Oncol. 2010, 37: 110-117. 10.1053/j.seminoncol.2010.03.002.
Article
PubMed
Google Scholar
Martin RCG, Rustein L, Pérez Enguix D, Palmero J, Carvalheiro V, Urbano J, Valdata A, Kralj I, Bosnjakovic P, Tatum C: Hepatic arterial infusion of doxorubicin-loaded microsphere for treatment of hepatocellular cancer: a multi-institutional registry. J Am Coll Surg. 2011, 213: 493-500. 10.1016/j.jamcollsurg.2011.07.010.
Article
PubMed
Google Scholar
Carr BI, Bron K, Swanson DP: Prospective randomized trial of hepatic artery chemotherapy with cisplatin and doxorubicin, with or without lipiodol in the treatment of advanced stage hepatocellular carcinoma. J Clin Gastroenterol. 2011, 45: e87-91. 10.1097/MCG.0b013e31820fb274.
Article
CAS
PubMed
Google Scholar
Ueshima K, Kudo M, Takita M, Nagai T, Tatsumi C, Ueda T, Kitai S, Ishikawa E, Yada N, Inoue T, Hagiwara S, Minami Y, Chung H: Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma. Oncol. 2010, 78 (Suppl 1): 148-153.
Article
CAS
Google Scholar
Smith GW, Bukowski RM, Hewlett JS, Groppe CW: Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma. Cancer. 1984, 54: 1513-1516. 10.1002/1097-0142(19841015)54:8<1513::AID-CNCR2820540806>3.0.CO;2-9.
Article
CAS
PubMed
Google Scholar
Inaba Y, Arai Y, Yamaura H, Sato Y, Najima M, Aramaki T, Sone M, Kumada T, Tanigawa N, Anai H, Yoshioka T, Ikeda M: Phase I/II study of hepatic arterial infusion chemotherapy with gemcitabine in patients with unresectable intrahepatic cholangiocarcinoma (JIVROSG-0301). Am J Clin Oncol. 2011, 34: 58-62. 10.1097/COC.0b013e3181d2709a.
Article
CAS
PubMed
Google Scholar
Tanaka N, Yamakado K, Nakatsuka A, Fujii A, Matsumura K, Takeda K: Arterial chemoinfusion therapy through an implanted port system for patients with unresectable intrahepatic cholangiocarcinoma–initial experience. Eur J Radiol. 2002, 41: 42-48. 10.1016/S0720-048X(01)00414-4.
Article
PubMed
Google Scholar
Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, Turnbull AD, Sullivan D, Stockman J, Blumgart LH, Fong Y: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999, 341: 2039-2048. 10.1056/NEJM199912303412702.
Article
CAS
PubMed
Google Scholar